Fiasp [package insert]. Plainsboro, NJ: Novo Nordisk Inc; June 2023. Diabetes Other Therapy Areas Indications and Usage for Fiasp®(insulin aspart) injection 100 U/mL Fiasp®(insulin aspart) injection 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult ...
Never Share a NovoLog®Mix 70/30 FlexPen®, Needle, or Syringe Between Patients, even if the needle is changed.Patients using NovoLog®Mix 70/30 vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. ...
Separate prescription for pen needles if prescribing FlexTouch®(if necessary) Avoid mix-ups at the pharmacy Fiasp®and NovoLog®(insulin aspart) injection 100 U/mL share the same generic, so it is important to specify the Fiasp®brand name on your script to avoid confusion at ...
Once a cartridge or a NovoLog® Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart injection) FlexPen® Prefilled syringe is punctured, it may be used for up to 14 days if it is kept at room temperature below 30°C (86°F). Cartridges or NovoLog® Mix 5...
doi:10.1016/j.jval.2019.04.667S. MurthyP. AnejaA. AsirvathamB. RamabhatL.L. Nystrup HusemoenN.A. RheeJ. KesavadevElsevier BVValue in Health
Fiasp [package insert]. Plainsboro, NJ: Novo Nordisk Inc; June 2023. Russell-Jones D, Bode BW, De Block C, et al. Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-targ...